EditorialPract Radiat Oncol2022
PROshot: Locoregional Therapy for Metastatic Breast Cancer, Abiraterone in Very High-Risk Prostate Cancer, Neoadjuvant Chemoradiation for Resectable Pancreatic Cancer, Radiation for Oligometastatic EGFR-mutated Lung Cancer, and PORT for N2 Lung Cancer.
- Journal
- Pract Radiat Oncol
- Published
- 1 May 2022
- Citations
- 0
- Type
- Editorial
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try